Shares of Amgen Inc. AMGN inched 0.08% higher to $278.32 Tuesday, on what proved to be an all-around mixed trading session ...

Patients with recurrent platinum-sensitive ovarian cancer did just as well with cytoreductive surgery alone as they did with ...

Amgen's new obesity drug, MariTide, shows promise against giants Eli Lilly and Novo Nordisk, but faces tough competition in a ...

The donation to Rush’s orthopedic department, the largest ever, creates four new endowed positions and programs.

Following a pair of similar deals in January and June, Coherus BioSciences has netted itself a hefty chunk of change for the ...

Sanofi just made its largest investment thus far in China. The company has committed just over $1 billion to build a new ...

"This is an exciting time to be joining Tonix as it prepares to receive an FDA decision on its NDA for TNX-102 SL for the ...

Shares of Janux Therapeutics skyrocketed Tuesday on "unprecedented" results for an experimental prostate cancer treatment.

German biotech asks federal judge to reject Amgen’s efforts to narrow scope of a key patent in ongoing dispute | Patent ...

There's a growing number of companies entering the weight loss space, focusing on GLP-1 drugs which can be game changers for ...

According to a U.S. News & World Report study, companies with high marks range from Amgen in Thousand Oaks to Monrovia-based ...

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...